JANUX THERAPEUTICS INC (JANX) Stock Analyst Earnings Estimates
NASDAQ:JANX - Nasdaq - US47103J1051 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.64M | 8.61M 136.54% | 8.083M -6.12% | 11.289M 39.66% | 3.109M -72.46% | 9.063M 191.51% | 8.395M -7.37% | 89.49M 965.99% | 393.82M 340.07% | 881.81M 123.91% | 1.266B 43.57% | 1.778B 40.44% | |
| EBITDA YoY % growth | -32.82M -579.50% | -66.25M -101.86% | -71.024M -7.21% | -104.611M -47.29% | -138.047M -31.96% | -149.665M -8.42% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -32.93M -580.37% | -67.09M -103.74% | -72.979M -8.78% | -101.667M -39.31% | -141.101M -38.79% | -180.466M -27.90% | -206.749M -14.56% | -190.763M 7.73% | -11.838M 93.79% | 336.15M 2,939.64% | 601.36M 78.90% | 971.02M 61.47% | |
| Operating Margin | -904.67% | -779.21% | -902.87% | -900.58% | -4,538.47% | -1,991.24% | -2,462.76% | -213.17% | -3.01% | 38.12% | 47.50% | 54.61% | |
| EPS YoY % growth | N/A | -1.52 -19.43% | -1.34 11.84% | -1.39 -3.78% | -2.06 -48.17% | -2.65 -28.78% | -3.67 -38.34% | -3.18 13.30% | -0.92 71.21% | 3.55 487.77% | 5.80 63.14% | 8.22 41.79% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.46 -85.98% | -0.46 -52.15% | -0.51 -367.11% | -0.58 -13.00% | -0.67 -44.24% | -0.88 -92.63% | -1.01 -95.83% | -1.04 -80.80% | -1.09 -61.83% |
| Revenue Q2Q % growth | 456.215K -81.46% | 255K -79.63% | 255K -97.13% | 318.75K -27.39% | 318.75K -30.13% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -34.109M -140.51% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -30.401M -88.39% | -26.979M -33.82% | -28.28M -104.60% | -31.11M 13.20% | -33.737M -10.97% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.51 -104.00% | -0.33 | -0.18 | -52.65% |
| Q2 2024 Q2Q % growth | -0.11 73.81% | -0.32 | 0.21 | 65.71% |
| Q1 2024 Q2Q % growth | -0.30 28.57% | -0.34 | 0.04 | 11.21% |
| Q4 2023 Q2Q % growth | -0.25 35.90% | -0.40 | 0.15 | 37.59% |
| Q3 2023 Q2Q % growth | -0.25 37.50% | -0.48 | 0.23 | 47.85% |
| Q2 2023 Q2Q % growth | -0.42 -2.44% | -0.53 | 0.11 | 20.43% |
| Q1 2023 Q2Q % growth | -0.42 -31.25% | -0.50 | 0.08 | 16.27% |
| Q4 2022 Q2Q % growth | -0.39 -18.18% | -0.50 | 0.11 | 21.41% |
| Q3 2022 Q2Q % growth | -0.40 -53.85% | -0.50 | 0.10 | 19.47% |
| Q2 2022 Q2Q % growth | -0.41 33.87% | -0.38 | -0.03 | -8.25% |
| Q1 2022 Q2Q % growth | -0.32 | -0.38 | 0.06 | 14.75% |
| Q4 2021 Q2Q % growth | -0.33 | -0.31 | -0.02 | -5.27% |
| Q3 2021 Q2Q % growth | -0.26 | -0.18 | -0.08 | -44.28% |
| Q2 2021 Q2Q % growth | -0.62 | -0.13 | -0.49 | -367.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 439K -82.56% | 1.674M | -1.235M | -73.78% |
| Q2 2024 Q2Q % growth | 8.897M 741.72% | 782.789K | 8.114M | 1,036.58% |
| Q1 2024 Q2Q % growth | 1.252M -38.87% | 778.648K | 473.352K | 60.79% |
| Q4 2023 Q2Q % growth | 2.461M -13.65% | 754.035K | 1.707M | 226.38% |
| Q3 2023 Q2Q % growth | 2.517M 39.06% | 862.41K | 1.655M | 191.86% |
| Q2 2023 Q2Q % growth | 1.057M -55.40% | 892.5K | 164.5K | 18.43% |
| Q1 2023 Q2Q % growth | 2.048M 28.81% | 685.695K | 1.362M | 198.68% |
| Q4 2022 Q2Q % growth | 2.85M 75.93% | 808.095K | 2.042M | 252.68% |
| Q3 2022 Q2Q % growth | 1.81M 56.03% | 758.197K | 1.052M | 138.72% |
| Q2 2022 Q2Q % growth | 2.37M 393.75% | 863.603K | 1.506M | 174.43% |
| Q1 2022 Q2Q % growth | 1.59M 318.42% | 834.697K | 755.303K | 90.49% |
| Q4 2021 Q2Q % growth | 1.62M | 441.997K | 1.178M | 266.52% |
| Q3 2021 Q2Q % growth | 1.16M | 135.997K | 1.024M | 752.96% |
| Q2 2021 Q2Q % growth | 480K | 204K | 276K | 135.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.01% | -15% | -1.47% | -13.4% |
| Revenue | 66.34% | -69.28% | 0% | -16.02% |